PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for December 7, 2002 Subscribe to this News Feed    
 

ClinPhone Remains One Of The UK's Fastest Growing Companies

ClinPhone Group - the clinical trial management organisation - retains its reputation as one of the fastest growing technology companies in the country according to the latest Deloitte & Touche Technology Fast 50 report.

Nottingham, UK - 5 December 2002 - ClinPhone Group - the clinical trial management organisation - retains its reputation as one of the fastest growing technology companies in the country according to the latest Deloitte & Touche Technology Fast 50 report.

For ClinPhone - ranked 11th in the Midlands region with 180% growth - it was the fourth time in a row it has made the prestigious Fast 50 list. The programme tracks the growth rates of technology companies operating in the telecommunications, hardware, software and biotechnology markets across seven regions in the UK and Ireland.

It is co-sponsored by techMARK, the London Stock Exchange market for technology companies. Eligibility is based on percentage turnover growth over the previous three-year period.

ClinPhone's performance follows a strong showing in 2001, when it was ranked 23rd with a growth rate of 117%. It was also ranked third in 1999 and seventh in 2000.

Since then it has continued to develop its business and its marketplace. It has expanded its operation in Nottingham with new facilities and more staff and achieved significant growth in its operations in the United States. Staff levels at all of the company's global offices have also increased due to greater demand. In the first half of the current financial year, the workforce grew to more than 320 in total. Around 80 operational and commercial staff now work in the United States, double the 2001 amount.

The ClinPhone Group is now the largest and most experienced industry specialist in global e-clinical trial management, having supported more than 720 clinical trials in over 80 countries and almost 70 languages.

It designs, develops and manages telephone and Internet-based IT applications that dramatically reduce costs and improve the efficiency of conducting clinical trials. Its systems are unique within the sector and are now regarded as the industry standard.

ends

For further information, please contact:

Richard Gee   +44 115 9508399   enquiries@gbcspr.com
Sally Kent   +44 115 9557333   skent@clinphone.com

----------

THIS RELEASE HAS BEEN DISTRIBUTED BY WEBITPR (www.webitpr.com)

Disclaimer:

Whilst WebitPR.com Limited endeavour to ensure the accuracy of the information contained in this Release, WebitPR.com Limited cannot accept any liability for:-

·   the inaccuracy or otherwise of any information contained in this Release; or
·   any loss liability or expense which may be suffered by any party in consequence of acting or omitting to act as a result of any information contained in or omitted from this Release.; or
·   any loss or suffering which may be caused by or to any party either as a result of the information contained in this Release or such information contained in this Release being inaccurate or otherwise misleading.

In the event that any information contained in this Release is inaccurate or misleading then please contact WebitPR.com at the above e-mail address.

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Jonathan Dolby
WebitPR
+44 (0) 1522 883640
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.